Search results
10 hours ago · A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up. Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Ajanta Pharma (NSE:AJANTPHARM). Even if this company is fairly valued by ...
5 hours ago · Infact, shares of several pharma companies--Suven Pharma, Ajanta Pharma, Divi's Laboratories, Laurus Labs and Syngene International also surged to their highest levels in 52-weeks.
10 hours ago · Shares of Pharma companies manufacturing anti-cancer drugs rallied up to 4.4 per cent as Finance Minister Nirmala Sitharaman in the 54th GST council meeting announced that the Goods and Services Tax (GST) on cancer drugs will be reduced to 5 per cent from an earlier 12 per cent. This tax cut, aimed at reducing the cost of cancer treatment in ...
5 hours ago · On that account, shares of AstraZeneca Pharma surged over 4 percent in trade to hit an intraday high of Rs 7,089.95 on the NSE. Meanwhile, the tax cut also aided sentiment for other pharma companies as well, largely on expectations that it will provide incentives to other drugmakers to dive into oncology drugs.
10 hours ago · Shares of Indian pharmaceutical companies rose following the GST Council’s decision to cut taxes on cancer drugs from 12% to 5%. Divi’s Laboratories, Suven Pharma, and Piramal Pharma each climbed over 3%, with Suven Pharma, Ajanta Pharma, Divi’s Laboratories, Laurus Labs, and Syngene International reaching new 52-week highs.
10 hours ago · Gadgil highlights the company's goal to reach 60 stores by FY27 and expand to 100-120 stores over the following six years. ... Ajanta Pharma Ltd. (3,399.05, 3.1% ...
People also ask
What is Ajanta Pharma?
Who is Managing Director of Ajanta Pharma Limited?
Where does Ajanta Pharma export products?
What is Ajanta Pharma Limited's authorized share capital & paid up capital?
10 hours ago · Best Tax Saver Funds Funds that combine wealth creation with tax saving under Section 80C